Live tape
Top 8, mentions 7d15,556MSFT3,075 mentions▲ +0.09GOOGL2,146 mentions▲ +0.05AAPL2,105 mentions▲ +0.07META2,077 mentions▲ +0.04SNDK1,811 mentions▲ +0.06NVDA1,590 mentions▲ +0.07SPCX1,535 mentions▲ +0.06QQQ1,217 mentions▲ +0.04

Equity · Healthcare

CPRX

Catalyst Pharmaceuticals, Inc. · NasdaqCM

$31.49 −0.06% 1D Finazon · prior-day close · Jul 14, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of CPRX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 52 sessions over that window: $29.00 on 4 May 2026 through $31.49 on 14 July 2026. Finazon · prior-day close.

Market cap $3.9B
P/E (TTM) 17.7
52-week range $19.12 – $31.51
Avg volume 359.1K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

CPRX insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 15

Showing the 12 most recent of 15 filings in this window. The figures above count all of them.

Compensation mechanics (12 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Jul 2026 Andrews William T. Chief Medical Officer Other 2,309 $73K
15 Jul 2026 Daly Richard J President and CEO Other 271,266 $8.54M
15 Jul 2026 Del Carmen Jeffrey Chief Commercial Officer Other 14,337 $452K
15 Jul 2026 DENKHAUS DONALD A Director Other 498,773 $15.71M
15 Jul 2026 Elsbernd Brian Chief Legal Officer Other 242,501 $7.64M
15 Jul 2026 Harper Molly Director Other 3,694 $116K
15 Jul 2026 Kalb Michael Wayne Chief Financial Officer Other 13,665 $430K
15 Jul 2026 MCENANY PATRICK J Director Other 4,171,559 $131.40M
15 Jul 2026 Miller Steve Chief Op. & Scientific Officer Other 1,093,803 $34.45M
15 Jul 2026 Russo Gregg Chief HR Officer Other 476 $15K
15 Jul 2026 Sundaram Preethi Chief Strategy Officer Other 54,804 $1.73M
15 Jul 2026 Thompson Tamar Director Other 3,773 $119K

CPRX reported financials

SEC EDGAR XBRL

CPRX reported revenue of $589.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $214.3M.

Figure Reported Period
Revenue $589.0M 31 Dec 2025 fiscal year
Net income $214.3M 31 Dec 2025 fiscal year
Diluted EPS $1.68 31 Dec 2025 fiscal year
Total assets $1.1B 31 Mar 2026 at period end
Total equity $1.0B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

CPRX earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.50 —
31 Dec 2025 FY 2025 $1.68 —
30 Sep 2025 Q3 2025 $0.42 —
30 Jun 2025 Q2 2025 $0.41 —

Reported figures & scheduled dates · SEC EDGAR filings

CPRX institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a CPRX position for the quarter ended 31 Mar 2026 — a combined $139.3M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −11.4% shares 2,347,477 $58.1M
Fundsmith Trimmed −74.9% shares 844,887 $20.9M
Millennium Management Held (±25%) −22.8% shares 766,991 $19.0M
Citadel Advisors Added +88.4% shares 581,093 $14.4M
Point72 Asset Management New position 425,865 $10.5M
AQR Capital Management Held (±25%) −24.8% shares 228,351 $5.7M
Marshall Wace Added +1,425.8% shares 201,815 $5.0M
Man Group Trimmed −54.5% shares 85,838 $2.1M
Fisher Asset Management Held (±25%) −0.8% shares 82,169 $2.0M
D. E. Shaw & Co. Added +276.1% shares 40,542 $1.0M

Source: SEC EDGAR 13F filings

CPRX fails-to-deliver

SEC CNS data

On 30 Jun 2026, 53 shares of CPRX failed to deliver (about $2K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 53 $2K <0.001%
29 Jun 2026 168,845 $5.3M 0.138%
25 Jun 2026 1,872 $59K 0.002%
16 Jun 2026 4,411 $138K 0.004%

Source: SEC fails-to-deliver (CNS) data